GROW Fundamental Analysis - U.S. GLOBAL INVESTORS INC-A

Fundamental Rating

Overall GROW gets a fundamental rating of 3 out of 10. We evaluated GROW against 238 industry peers in the Capital Markets industry. No worries on liquidiy or solvency for GROW as it has an excellent financial health rating, but there are worries on the profitability. GROW has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year GROW has reported negative net income.

In the past year GROW has reported a negative cash flow from operations.

GROW had positive earnings in 4 of the past 5 years.

Of the past 5 years GROW 4 years had a positive operating cash flow.

1.2 Ratios

GROW has a worse Return On Assets (-0.69%) than 75.63% of its industry peers.

Looking at the Return On Equity, with a value of -0.74%, GROW is doing worse than 73.11% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-0.69%
ROE	-0.74%
ROIC	N/A

ROA(3y)2.51%

ROA(5y)12.94%

ROE(3y)2.67%

ROE(5y)14.64%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

GROW does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GROW has less shares outstanding than it did 1 year ago.

The number of shares outstanding for GROW has been reduced compared to 5 years ago.

The debt/assets ratio for GROW is higher compared to a year ago.

2.2 Solvency

GROW has an Altman-Z score of 8.38. This indicates that GROW is financially healthy and has little risk of bankruptcy at the moment.

GROW has a Altman-Z score of 8.38. This is amongst the best in the industry. GROW outperforms 92.44% of its industry peers.

GROW has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.

GROW has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. GROW outperforms 86.55% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	8.38

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 20.87 indicates that GROW has no problem at all paying its short term obligations.

GROW's Current ratio of 20.87 is amongst the best of the industry. GROW outperforms 98.32% of its industry peers.

GROW has a Quick Ratio of 20.87. This indicates that GROW is financially healthy and has no problem in meeting its short term obligations.

GROW has a Quick ratio of 20.87. This is amongst the best in the industry. GROW outperforms 98.32% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	20.87
Quick Ratio	20.87

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for GROW have decreased strongly by -128.19% in the last year.

GROW shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.97%.

The Revenue has been growing by 14.64% on average over the past years. This is quite good.

EPS 1Y (TTM)-128.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-160.79%

Revenue 1Y (TTM)67.97%

Revenue growth 3Y-32.43%

Revenue growth 5Y14.64%

Sales Q2Q%-29.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

GROW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

GROW has a Yearly Dividend Yield of 3.72%.

GROW's Dividend Yield is comparable with the industry average which is at 6.43.

Compared to an average S&P500 Dividend Yield of 1.87, GROW pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	3.72%

5.2 History

On average, the dividend of GROW grows each year by 24.71%, which is quite nice.

GROW has been paying a dividend for at least 10 years, so it has a reliable track record.

GROW has decreased its dividend recently.

Dividend Growth(5Y)24.71%

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

GROW has negative earnings and hence a negative payout ratio. The dividend may be in danger.

DP-361.68%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

U.S. GLOBAL INVESTORS INC-A

NASDAQ:GROW (12/19/2025, 8:00:01 PM)

2.38

-0.04 (-1.65%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)11-13 2025-11-13

Earnings (Next)02-11 2026-02-11

Inst Owners34.29%

Inst Owner Change-14.59%

Ins Owners6.24%

Ins Owner Change1.53%

Market Cap30.44M

Revenue(TTM)8.87M

Net Income(TTM)-334.00K

Analysts0

Price TargetN/A

Short Float %0.04%

Short Ratio0.1

Dividend

		Industry Rank	Sector Rank
Dividend Yield	3.72%

Yearly Dividend0.09

Dividend Growth(5Y)24.71%

DP-361.68%

Div Incr Years1

Div Non Decr Years1

Ex-Date02-09 2026-02-09 (0.0075)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.43
P/FCF	N/A
P/OCF	N/A
P/B	0.67
P/tB	0.67
EV/EBITDA	N/A

EPS(TTM)-0.03

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.06

FCFYN/A

OCF(TTM)-0.06

OCFYN/A

SpS0.69

BVpS3.53

TBVpS3.53

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-0.69%
ROE	-0.74%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)2.51%

ROA(5y)12.94%

ROE(3y)2.67%

ROE(5y)14.64%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.18

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	0.08%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	20.87
Quick Ratio	20.87
Altman-Z	8.38

F-Score3

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)1.39%

Cap/Sales(5y)1.02%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-128.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-160.79%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)67.97%

Revenue growth 3Y-32.43%

Revenue growth 5Y14.64%

Sales Q2Q%-29.74%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y58.45%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-206.69%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-183.03%

OCF growth 3YN/A

OCF growth 5YN/A

U.S. GLOBAL INVESTORS INC-A / GROW FAQ

What is the fundamental rating for GROW stock?

ChartMill assigns a fundamental rating of 3 / 10 to GROW.

What is the valuation status for GROW stock?

ChartMill assigns a valuation rating of 0 / 10 to U.S. GLOBAL INVESTORS INC-A (GROW). This can be considered as Overvalued.

Can you provide the profitability details for U.S. GLOBAL INVESTORS INC-A?

U.S. GLOBAL INVESTORS INC-A (GROW) has a profitability rating of 1 / 10.

U.S. GLOBAL INVESTORS INC-A (GROW) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

U.S. GLOBAL INVESTORS INC-A / GROW FAQ

What is the fundamental rating for GROW stock?

What is the valuation status for GROW stock?

Can you provide the profitability details for U.S. GLOBAL INVESTORS INC-A?